Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lotus Biosciences is a biotechnology company specializing in non-invasive diagnostic solutions through a proprietary multi-omics platform. The company's core technology utilizes a patent-pending adhesive tape system to capture genomic, proteomic, and metabolomic data directly from skin samples. This approach enables precise biomarker discovery and disease monitoring for complex conditions such as Parkinson's disease, oncology, and neurodegeneration. By offering scalable tools for both in-clinic and remote specimen collection, Lotus Biosciences supports pharmaceutical partners and clinical researchers in advancing personalized medicine and decentralized clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lotus Biosciences.